Year in Review
- 2020 Year in Review [PDF 8.2 MB]
About us
The next few pages give you an overview of what we do and don’t do, our role in New Zealand’s health system, and how we are improving health outcomes for Māori and Pacific peoples.
- About us
- Working with Māori for positive Māori health outcomes
- Working in partnership to get better health outcomes
Our work in 2019/20
Ā mātou mahi i te tau 2019/20
The following pages highlight the impacts we made in 2019/20. The stories show you what our work means for the people who can now access these funded medicines. We’ve also included some insights into the volumes and costs of medicines.
- The year in numbers
- New Zealanders are getting more medicines
- New Zealand is controlling medicines expenditure over time
- More contraceptive options
- Preventing the spread of diseases in our communities
- Improving access to rare disorders medicines
- Maviret is still changing lives
- More cancer medicines
- Fairer access to medical devices
- Supporting the COVID-19 response
Top 20 medicines by Therapeutic Groups gross spend
Top 20 community medicines by number of funded prescriptions dispensed
Top 20 hospital medicines by gross spend
Top 20 reimbursed medicines by gross spend
How we make decisions
Te ara whakaputa whakatau
We understand how important getting access to funded medicines and related products are. These next few pages go through some of the processes we use when deciding whether to fund a medicine and the expert clinical and consumer feedback we draw on.